Product Information
ENOXAPARIN 30 MG/0.3 ML SYR is a generic product labeled by Fresenius Kabi USA, LLC, priced at $9.1268 per ML under NDC 63323055965. Its NADAC has been published 226 times since Jun 8, 2022.
FDA first approved this application on Sep 28, 2018. Its Orange Book therapeutic-equivalence code is AP.
Strength
30 mg/.3mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323055965
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078990FDA Approved
9/28/2018
TE Code
AP
On Market Since
4/23/2019
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 30 MG/0.3 ML SYR has been published 226 times since Jun 8, 2022, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.1268 per ML |
|---|---|
| All-time high | $16.6351 (Jun 15, 2022) |
| All-time low | $7.6552 (Nov 20, 2024) |
| 52-week high | $9.6795 |
| 52-week low | $8.6611 |
| Median price | $11.4486 |
| Average price | $11.4468 |
| Largest weekly change | -30.8% (Nov 20, 2024) |
| Weeks tracked | 226 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Enoxaparin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Low Molecular Weight Heparin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENOXAPARIN 30 MG/0.3 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 30 MG/0.3 ML SYR, manufactured by Fresenius Kabi USA, LLC, is $9.1268 per ML (NDC 63323055965), effective Sep 30, 2026.
How has the price of ENOXAPARIN 30 MG/0.3 ML SYR changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 30 MG/0.3 ML SYR has declined 45.1%. It has been tracked across 226 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 30 MG/0.3 ML SYR?
Since Jun 8, 2022, the NADAC for ENOXAPARIN 30 MG/0.3 ML SYR has ranged from a low of $7.6552 (Nov 20, 2024) to a high of $16.6351 (Jun 15, 2022), with a median of $11.4486 per ML.
Are there cheaper alternatives to ENOXAPARIN 30 MG/0.3 ML SYR?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 30 MG/0.3 ML SYR in a comparable dosage form, but none are currently priced below it.
Who manufactures ENOXAPARIN 30 MG/0.3 ML SYR?
ENOXAPARIN 30 MG/0.3 ML SYR (NDC 63323055965) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.